|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/19 | (2006.01) |
| A61K 31/475 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/65 | (2006.01) | ||
| A61K 31/66 | (2006.01) | ||
| A61K 31/70 | (2006.01) | ||
| A61K 33/24 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1423105 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02758562.9 |
| Date of filing the European patent application | 2002-09-03 | |
| (97) | Date of publication of the European application | 2004-06-02 |
| (45) | Date of publication and mention of the grant of the patent | 2008-12-03 |
| (46) | Date of publication of the claims translation | 2009-03-25 |
| (86) | Number | PCT/GB2002/004025 |
| Date | 2002-09-03 |
| (87) | Number | WO 2003/020259 |
| Date | 2003-03-13 |
| (30) | Number | Date | Country code |
| 0121285 | 2001-09-03 | GB |
| (72) |
WILSON, William, Robert, NZ
SIIM, Bronwyn, Gae, NZ
|
| (73) |
Cancer Research Technology Limited,
Sardinia House, Sardinia Street London WC2A 3NL,
GB
|
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | DMXAA ir kitų priešvėžinių agentų deriniai |
| COMBINATIONS OF DMXAA AND OTHER ANTI-CANCER AGENTS |
| Payment date | Validity (years) | Amount | |
| 2010-08-12 | 9 | 720.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2011-09-03 |